Catapres vs. Tricor: side effect and effectiveness comparison (a real world drug study)
Summary:
We compare the side effects and drug effectiveness of Catapres and Tricor. The phase IV clinical study is created by eHealthMe based on reports (from sources including the FDA) of 80,854 people who take Catapres and Tricor, and is updated regularly.
What is Catapres?
Catapres has active ingredients of clonidine hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 6,680 Catapres users. Check the latest studies of Catapres.
What is Tricor?
Tricor has active ingredients of fenofibrate. It is often used in high blood cholesterol. eHealthMe is studying from 22,641 Tricor users. Check the latest studies of Tricor.
80,854 people who take Catapres and Tricor are studied.

Drugs being compared in this study:
- Catapres (clonidine hydrochloride)
- Tricor (fenofibrate)
Most common side effects of the drugs, overall:
Most common side effects of the drugs, in long term (1+ years) use:
Drug effectiveness:
Catapres:
- not at all: 5.18 %
- somewhat: 25.38 %
- moderate: 36.36 %
- high: 21.97 %
- very high: 11.11 %
Tricor:
- not at all: 2.76 %
- somewhat: 17.45 %
- moderate: 38.72 %
- high: 30.93 %
- very high: 10.15 %
Want to compare Catapres with Tricor?
- Personalize this study to your gender and age (0-99+)How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related studies
Alternative drugs to, pros and cons of:
Browse all side effects of Catapres:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Tricor:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study is based on clonidine hydrochloride and fenofibrate (the active ingredients of Catapres and Tricor, respectively). Other drugs that have the same active ingredients (e.g. generic drugs or brand names) are also considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Adapalene cause Rashes? - 4 seconds ago
- Vyvanse and Diclofenac drug interactions for women aged 40-49 - 5 seconds ago
- Drug interactions of Lamotrigine and Buprenorphine - 8 seconds ago
- Could Halcion cause Upper Respiratory Tract Infection? - 12 seconds ago
- Depo-Provera and Ih for Women aged 20-29 - 16 seconds ago
- Depo-Provera and Intracranial Hypertension for Women aged 20-29 - 17 seconds ago
- Could Ketoconazole cause Abnormal Faeces? - 17 seconds ago
- Depo-Provera and Idiopathic Intracranial Hypertension for Women aged 20-29 - 17 seconds ago
- Depo-Provera and Benign Intracranial Hypertension for Women aged 20-29 - 17 seconds ago
- Depo-Provera and Pseudotumor Cerebri for Women aged 20-29 - 17 seconds ago